Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.99 is in line with its 5-year average of -1.95, around the middle of its 5-year range (-4.44–-0.29).
126.34% below its 12-month average of -0.88.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.99
EARNINGS PER SHARE (EPS) AVG TTM
-0.88
EARNINGS PER SHARE (EPS) AVG 3Y
-1.91
EARNINGS PER SHARE (EPS) AVG 5Y
-1.95
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-126.34%
CURRENT VS 3Y AVG
-3.92%
CURRENT VS 5Y AVG
-2.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Bright Minds Biosciences Inc.
Market Cap
$474.97M
Earnings Per Share (EPS)
-1.99
TTM Avg
-0.88
3Y Avg
-1.91
5Y Avg
-1.95
Market Cap
$472.58M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.10
3Y Avg
-0.16
5Y Avg
-0.22
Market Cap
$478.28M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.81
3Y Avg
-1.01
5Y Avg
-1.63
Market Cap
$478.75M
Earnings Per Share (EPS)
0.16
TTM Avg
-2.02
3Y Avg
-3.99
5Y Avg
-3.80
Market Cap
$462.71M
Earnings Per Share (EPS)
-1.73
TTM Avg
-1.90
3Y Avg
-1.16
5Y Avg
-1.16
Market Cap
$460.20M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
Market Cap
$457.20M
Earnings Per Share (EPS)
-0.72
TTM Avg
-0.65
3Y Avg
-0.60
5Y Avg
-0.64
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $474.97M | -1.99 | -0.88 | -1.91 | -1.95 |
| Cerus Corporation (CERS)vs › | $472.58M | -0.04 | -0.10 | -0.16 | -0.22 |
| Evolus, Inc. (EOLS)vs › | $478.28M | -0.52 | -0.81 | -1.01 | -1.63 |
| Arvinas, Inc. (ARVN)vs › | $478.75M | 0.16 | -2.02 | -3.99 | -3.80 |
| NRC Health (NRC)vs › | $463.35M | 0.25 | 0.79 | 1.03 | 1.18 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $462.71M | -1.73 | -1.90 | -1.16 | -1.16 |
| Kamada Ltd. (KMDA)vs › | $460.98M | 0.38 | 0.32 | 0.19 | 0.19 |
| NeoGenomics, Inc. (NEO)vs › | $460.20M | -1.98 | -3.65 | -4.15 | -2.79 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $457.20M | -0.72 | -0.65 | -0.60 | -0.64 |
| Assembly Biosciences, Inc. (ASMB)vs › | $443.61M | 0.55 | -3.62 | -10.86 | -15.74 |
Trailing EPS (TTM)
$-1.99
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | -1.28 |
| 2024-09-30 | -0.48 |
| 2023-09-30 | -1.46 |
| 2022-09-30 | -4.44 |
| 2021-09-30 | -3.74 |
| 2020-09-30 | -0.29 |
| 2019-09-30 | -0.05 |
